BioSpace News Archive

Press Releases

Microbix Assisting EMQN with Second Genetic-Test EQA Program

September 23, 2025
·
6 min read
Press Releases

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA

September 23, 2025
·
2 min read
Press Releases

SEED Therapeutics Completes $30 Million Series A-3 Financing

September 23, 2025
·
2 min read
Press Releases

FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility

September 23, 2025
·
8 min read
Press Releases

Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples

September 23, 2025
·
4 min read
Press Releases

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

September 23, 2025
·
4 min read
Press Releases

VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million

September 23, 2025
·
1 min read
Press Releases

New Subcutaneous Formulation of OPDIVO® Receives Positive INESSS Recommendation for Multiple Tumour Types

September 23, 2025
·
3 min read
Press Releases

New Study Highlights Urgent Need for RSV Prevention in Older Adults

September 23, 2025
·
4 min read
Press Releases

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026

September 23, 2025
·
12 min read